STAAR Surgical Company (STAA) Q4 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings report presents mixed signals: a 12% revenue increase and a 7% net income rise are positive, but the 1.5% decline in gross margin and lack of strategic or shareholder return updates are concerning. With a market cap of $2.3 billion, the stock is likely to have a muted reaction, placing it in the neutral range (-2% to 2%).
Key Financial Performance
Revenue $92.5 million, an increase of 12% year-over-year, driven by strong sales in the Asia-Pacific region and robust demand for EVO lenses.
Gross Margin 75.2%, a decrease of 1.5 percentage points year-over-year, due to higher manufacturing costs and unfavorable product mix.
Operating Income $18.3 million, a 5% increase year-over-year, attributed to higher revenue partially offset by increased operating expenses.
Net Income $14.7 million, up 7% year-over-year, reflecting improved operating income and lower interest expenses.
Cash Flow from Operations $20.1 million, a 10% increase year-over-year, driven by higher net income and efficient working capital management.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Forward-looking statements disclaimer: The company acknowledges that forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those expressed or implied.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Forward-looking statements: During today's discussion, we will be making forward-looking statements. Forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those expressed or implied by such forward-looking statements.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Review of Unclear Management Responses
A:
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Adam Maeder
Andrews Interim
BTIG LLC
Bowers Mizuho
Bradley Bowers
CEO President
COO Deborah
Canaccord Genuity
Carrico Stephens
Co CEO
Co Research
Conference Instructions
Corp Research
Deborah Andrews
Director Investor
Division Adam
Division Bradley
Division Gursimran
Division Iseult
Division Mason
Division Saxon
Division Young
Division day
EST Warren
Fargo Securities
Financial Results
Foust Interim
Genuity Corp
Interim Co
LLC Research
Research Division
STAA Transcript
STAAR Surgical Company (STAA) Q1 2026 Earnings Call Transcript
Unknown5-14
The earnings call revealed strong financial performance and optimistic product development, especially with EVO+. However, management's reluctance to provide guidance, coupled with macroeconomic uncertainties and potential margin pressures, tempers enthusiasm. The Q&A highlighted analysts' concerns about revenue targets and competitive pressures, but management remained optimistic about market stability and growth, particularly in China. The market cap suggests moderate volatility, but without clear guidance or strong catalysts, the stock is likely to remain stable, resulting in a neutral sentiment rating.
STAAR Surgical Company (STAA) Q4 2025 Earnings Call Transcript
Unknown3-4
The earnings report presents mixed signals: a 12% revenue increase and a 7% net income rise are positive, but the 1.5% decline in gross margin and lack of strategic or shareholder return updates are concerning. With a market cap of $2.3 billion, the stock is likely to have a muted reaction, placing it in the neutral range (-2% to 2%).
STAAR Surgical Company (STAA) Q1 2025 Earnings Call Transcript
Unknown5-7
The earnings report shows significant declines in net sales and gross margin, especially in China, and an EBITDA loss. The Q&A reveals management's unclear responses regarding competition impact and withdrawn guidance, causing analyst concern. Despite some positive developments in ICL sales and market strategy, the lack of a share repurchase program and restructuring charges further weigh negatively. Given the market cap, the negative aspects are likely to outweigh the positives, leading to a negative stock price reaction.
Earnings call transcript: STAAR Surgical misses Q1 2025 EPS forecast, stock dips
Unknown5-7
The earnings call revealed significant challenges: a massive decline in sales, especially in China, and a drop in gross margin. Despite some optimism about future demand and cost optimization, the withdrawal of guidance due to economic uncertainty and competitive pressures add to investor concerns. The lack of a shareholder return plan and refusal to provide clear guidance further dampen sentiment. Given the small market cap, these factors are likely to result in a negative stock price movement over the next two weeks.
STAA Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
